东星医疗
(301290)
| 流通市值：15.21亿 | | | 总市值：22.41亿 |
| 流通股本：6799.79万 | | | 总股本：1.00亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 91,814,686.88 | 433,734,971.84 | 311,118,638.38 | 201,802,103.61 |
| 营业收入 | 91,814,686.88 | 433,734,971.84 | 311,118,638.38 | 201,802,103.61 |
| 二、营业总成本 | 78,189,414.84 | 351,949,472.05 | 250,384,360.5 | 162,689,502.68 |
| 营业成本 | 48,552,852.6 | 224,328,531.48 | 161,776,445.66 | 104,037,290.33 |
| 税金及附加 | 972,207.02 | 4,097,310.89 | 2,773,597.99 | 1,801,896.22 |
| 销售费用 | 9,730,340.41 | 42,247,157.68 | 28,945,226.28 | 19,760,159.63 |
| 管理费用 | 15,853,821.74 | 64,636,739.2 | 45,475,859.91 | 29,997,318.49 |
| 研发费用 | 4,804,803.02 | 27,114,546.7 | 20,237,381.58 | 13,227,443.69 |
| 财务费用 | -1,724,609.95 | -10,474,813.9 | -8,824,150.92 | -6,134,605.68 |
| 其中:利息费用 | 21,341.81 | 63,085.83 | 57,152.46 | 85,257.1 |
| 其中:利息收入 | 1,764,325.73 | 10,618,364.34 | 8,981,112.92 | 6,269,127.93 |
| 加:公允价值变动收益 | -5,011,214.55 | 13,691,743.52 | 10,251,831.64 | 7,461,187.57 |
| 加:投资收益 | 12,082,100.02 | 5,632,204.66 | 2,942,830.99 | 1,164,099.77 |
| 资产处置收益 | -40,784 | -356,874.75 | 9,974.61 | 6,282.51 |
| 资产减值损失(新) | 34,179.01 | -883,605.17 | -193,976.04 | -102,843.26 |
| 信用减值损失(新) | 493,523.56 | -11,310.06 | 255,569.32 | 1,036,998.36 |
| 其他收益 | 2,663,709.8 | 17,148,704.43 | 13,100,464.28 | 12,691,983.93 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 23,846,785.88 | 117,006,362.42 | 87,100,972.68 | 61,370,309.81 |
| 加:营业外收入 | 24,809.31 | 317,649.31 | 313,085.72 | 106,625.18 |
| 减:营业外支出 | 104,464 | 260,407.98 | 14,852.82 | 10,971.75 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 23,767,131.19 | 117,063,603.75 | 87,399,205.58 | 61,465,963.24 |
| 减:所得税费用 | 4,174,090.5 | 17,181,128.05 | 13,796,860.79 | 9,628,367.75 |
| 六、净利润 | 19,593,040.69 | 99,882,475.7 | 73,602,344.79 | 51,837,595.49 |
| 持续经营净利润 | 19,593,040.69 | 99,882,475.7 | 73,602,344.79 | 51,837,595.49 |
| 归属于母公司股东的净利润 | 19,890,650.72 | 97,222,808.88 | 71,412,640.45 | 50,034,885.79 |
| 少数股东损益 | -297,610.03 | 2,659,666.82 | 2,189,704.34 | 1,802,709.7 |
| (一)基本每股收益 | 0.2 | 0.97 | 0.71 | 0.5 |
| (二)稀释每股收益 | 0.2 | 0.97 | 0.71 | 0.5 |
| 九、综合收益总额 | 19,593,040.69 | 99,882,475.7 | 73,602,344.79 | 51,837,595.49 |
| 归属于母公司股东的综合收益总额 | 19,890,650.72 | 97,222,808.88 | 71,412,640.45 | 50,034,885.79 |
| 归属于少数股东的综合收益总额 | -297,610.03 | 2,659,666.82 | 2,189,704.34 | 1,802,709.7 |
| 公告日期 | 2024-04-22 | 2024-04-22 | 2023-10-25 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |